Baroda BNP Paribas Health and Wellness Fund
The fund maintains a heavily pharma-centric positioning with two-thirds of assets in drugs and biotech, expecting sustained demand from India's aging population and rising healthcare spending. The manager's conviction shifted meaningfully this month—trimming a large hospital operator to upgrade pure-play pharma exposure and adding specialty drugmakers like Concord Biotech and Cohance, signaling confidence in high-margin segments over diversified healthcare conglomerates. With over half the portfolio in just ten stocks, returns hinge significantly on a narrow set of pharmaceutical winners.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Primary | ₹9.9143 | +6.32% | — | — | — |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| Concord Biotech Limited | 1.29% |
| Procter & Gamble Health Limited | 1.08% |
| Max Financial Services Limited | 1.05% |
| Cohance Lifesciences Limited | 0.96% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited INE044A01036 | 9.38% |
| 2 | Lupin Limited INE326A01037 | 6.09% |
| 3 | IPCA Laboratories Limited INE571A01038 | 5.34% |
| 4 | Abbott India Limited INE358A01014 | 5.28% |
| 5 | Torrent Pharmaceuticals Limited INE685A01028 | 5.13% |
| 6 | Laurus Labs Limited INE947Q01028 | 4.78% |
| 7 | Fortis Healthcare Limited INE061F01013 | 4.35% |
| 8 | Apollo Hospitals Enterprise Limited INE437A01024 | 4.32% |
| 9 | JB Chemicals & Pharmaceuticals Limited INE572A01036 | 4.24% |
| 10 | AstraZeneca Pharma India Limited INE203A01020 | 4.03% |
| 11 | Emcure Pharmaceuticals Limited INE168P01015 | 3.44% |
| 12 | SBI Life Insurance Company Limited INE123W01016 | 3.43% |
| 13 | Aster DM Healthcare Limited INE914M01019 | 2.97% |
| 14 | Clearing Corporation of India Ltd nan | 2.88% |
| 15 | ICICI Prudential Life Insurance Company Limited INE726G01019 | 2.81% |
| 16 | Glenmark Pharmaceuticals Limited INE935A01035 | 2.72% |
| 17 | Aurobindo Pharma Limited INE406A01037 | 2.62% |
| 18 | Dr. Lal Path Labs Limited INE600L01024 | 2.58% |
| 19 | Gland Pharma Limited INE068V01023 | 2.09% |
| 20 | Divi's Laboratories Limited INE361B01024 | 2.07% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does Baroda BNP Paribas Health and Wellness Fund hold?
Baroda BNP Paribas Health and Wellness Fund holds 36 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 31.22% of NAV.
What is the largest holding in Baroda BNP Paribas Health and Wellness Fund?
The largest position in Baroda BNP Paribas Health and Wellness Fund is Sun Pharmaceutical Industries Limited, accounting for 9.38% of NAV in the Pharmaceuticals & Biotechnology sector.
Is Baroda BNP Paribas Health and Wellness Fund a concentrated or diversified fund?
With a Gini coefficient of 0.360, Baroda BNP Paribas Health and Wellness Fund is well-diversified. The HHI concentration index is 40,733 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 31.22% of the portfolio.
What is the market cap allocation of Baroda BNP Paribas Health and Wellness Fund?
Based on SEBI's AMFI classification, Baroda BNP Paribas Health and Wellness Fund's equity portfolio is split as: Large Cap: 26.69%, Mid Cap: 36.31%, Small Cap: 34.26%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does Baroda BNP Paribas Health and Wellness Fund invest in most?
Baroda BNP Paribas Health and Wellness Fund has the highest allocation to Pharmaceuticals & Biotechnology (67.79%), Healthcare Services (17.89%), Insurance (7.29%). The fund is invested across 7 sectors in total.
How actively managed is Baroda BNP Paribas Health and Wellness Fund compared to other Sectoral / Thematic funds?
Baroda BNP Paribas Health and Wellness Fund has an Active Share of 89.97%, classifying it as "Highly Differentiated" among 237 Sectoral / Thematic peers. This means the fund takes significantly different stock positions compared to its category peers.
What changed in Baroda BNP Paribas Health and Wellness Fund's portfolio in the latest month?
Between 2026-03-31 and 2026-04-30, Baroda BNP Paribas Health and Wellness Fund added 4 new stocks (including Concord Biotech Limited) and exited 1 stock (including Max Healthcare Institute Limited). Total holding count increased from 34 to 37 stocks.